A detailed history of Raymond James & Associates transactions in Select Sector Spdr Fund Health stock. As of the latest transaction made, Raymond James & Associates holds 5,682,906 shares of XLV stock, worth $817 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares
5,682,906
Previous 5,600,102 1.48%
Holding current value
$817 Million
Previous $764 Million 9.92%
% of portfolio
0.58%
Previous 0.58%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$138.48 - $147.86 $11.5 Million - $12.2 Million
82,804 Added 1.48%
5,682,906 $840 Million
Q4 2023

Jan 16, 2024

BUY
$123.14 - $136.38 $46.6 Million - $51.6 Million
378,702 Added 7.25%
5,600,102 $764 Million
Q3 2023

Oct 24, 2023

BUY
$128.74 - $136.24 $15.3 Million - $16.2 Million
119,011 Added 2.33%
5,221,400 $672 Million
Q2 2023

Jul 25, 2023

BUY
$126.74 - $135.66 $51.2 Million - $54.8 Million
403,847 Added 8.6%
5,102,389 $677 Million
Q1 2023

Apr 14, 2023

SELL
$124.15 - $135.82 $25.2 Million - $27.6 Million
-203,102 Reduced 4.14%
4,698,542 $608 Million
Q4 2022

Feb 08, 2023

BUY
$129.86 - $140.1 $13.7 Million - $14.8 Million
105,540 Added 2.2%
4,901,644 $666 Million
Q3 2022

Oct 25, 2022

BUY
N/A
275,367 Added 6.09%
4,796,104 $581 Million
Q2 2022

Aug 12, 2022

BUY
N/A
863,876 Added 23.62%
4,520,737 $580 Million
Q1 2022

May 11, 2022

BUY
N/A
721,207 Added 24.57%
3,656,861 $501 Million
Q4 2021

Feb 08, 2022

BUY
N/A
361,933 Added 14.06%
2,935,654 $414 Million
Q3 2021

Nov 02, 2021

BUY
N/A
226,764 Added 9.66%
2,573,721 $328 Million
Q2 2021

Aug 11, 2021

BUY
N/A
322,980 Added 15.96%
2,346,957 $296 Million
Q1 2021

May 14, 2021

BUY
N/A
98,196 Added 5.1%
2,023,977 $236 Million
Q4 2020

Feb 12, 2021

SELL
N/A
-87,651 Reduced 4.35%
1,925,781 $218 Million
Q3 2020

Nov 04, 2020

BUY
N/A
100,458 Added 5.25%
2,013,432 $212 Million
Q2 2020

Jul 28, 2020

BUY
N/A
241,548 Added 14.45%
1,912,974 $191 Million
Q1 2020

Apr 21, 2020

BUY
N/A
242,947 Added 17.01%
1,671,426 $148 Million
Q4 2019

Feb 12, 2020

BUY
N/A
169,254 Added 13.44%
1,428,479 $146 Million
Q3 2019

Nov 07, 2019

BUY
N/A
114,445 Added 10.0%
1,259,225 $113 Million
Q2 2019

Aug 06, 2019

SELL
N/A
-16,065 Reduced 1.38%
1,144,780 $106 Million
Q1 2019

May 06, 2019

SELL
N/A
-51,735 Reduced 4.27%
1,160,845 $107 Million
Q4 2018

Feb 11, 2019

BUY
N/A
202,108 Added 20.0%
1,212,580 $105 Million
Q3 2018

Nov 14, 2018

BUY
N/A
22,511 Added 2.28%
1,010,472 $96.1 Million
Q2 2018

Aug 14, 2018

BUY
N/A
3,212 Added 0.33%
987,961 $82.5 Million
Q1 2018

May 14, 2018

BUY
N/A
58,616 Added 6.33%
984,749 $80.2 Million
Q4 2017

Feb 14, 2018

BUY
N/A
39,081 Added 4.41%
926,133 $76.6 Million
Q3 2017

Nov 13, 2017

BUY
N/A
244,803 Added 38.12%
887,052 $72.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
642,249
642,249 $50.9 Million

Others Institutions Holding XLV

About SELECT SECTOR SPDR FUND-HEALTH


  • Ticker XLV
  • Sector ETFs
  • Industry ETFs
More about XLV
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.